597 related articles for article (PubMed ID: 16474404)
21. Non-hodgkin lymphoma in a patient with cardiofaciocutaneous syndrome.
Ohtake A; Aoki Y; Saito Y; Niihori T; Shibuya A; Kure S; Matsubara Y
J Pediatr Hematol Oncol; 2011 Dec; 33(8):e342-6. PubMed ID: 20523244
[TBL] [Abstract][Full Text] [Related]
22. Clinical and molecular analysis of RASopathies in a group of Turkish patients.
Şimşek-Kiper PÖ; Alanay Y; Gülhan B; Lissewski C; Türkyilmaz D; Alehan D; Cetin M; Utine GE; Zenker M; Boduroğlu K
Clin Genet; 2013 Feb; 83(2):181-6. PubMed ID: 22420426
[TBL] [Abstract][Full Text] [Related]
23. Familial cardio-facio-cutaneous syndrome: Vertical transmission of the BRAF p.G464R pathogenic variant and review of the literature.
Rauen KA; Maeda Y; Egense A; Tidyman WE
Am J Med Genet A; 2021 Feb; 185(2):469-475. PubMed ID: 33274568
[TBL] [Abstract][Full Text] [Related]
24. Gene symbol: BRAF. Disease: Cardio-facio-cutaneous syndrome.
Cave H
Hum Genet; 2008 Feb; 123(1):108. PubMed ID: 18386340
[No Abstract] [Full Text] [Related]
25. Germline mutations in HRAS proto-oncogene cause Costello syndrome.
Aoki Y; Niihori T; Kawame H; Kurosawa K; Ohashi H; Tanaka Y; Filocamo M; Kato K; Suzuki Y; Kure S; Matsubara Y
Nat Genet; 2005 Oct; 37(10):1038-40. PubMed ID: 16170316
[TBL] [Abstract][Full Text] [Related]
26. [Molecular genetic diagnostics in syndromes associated with the RAS/MAPK signalling pathway].
Molven A; Søvik O; von der Lippe C; Steine SJ; Njølstad PR; Houge G; Prescott TE
Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2358-61. PubMed ID: 19935936
[TBL] [Abstract][Full Text] [Related]
27. Dermatological findings in 61 mutation-positive individuals with cardiofaciocutaneous syndrome.
Siegel DH; McKenzie J; Frieden IJ; Rauen KA
Br J Dermatol; 2011 Mar; 164(3):521-9. PubMed ID: 21062266
[TBL] [Abstract][Full Text] [Related]
28. Gene symbol: KRAS. Disease: Cardio-facio-cutaneous syndrome.
Cave H
Hum Genet; 2008 Feb; 123(1):107-8. PubMed ID: 18386339
[No Abstract] [Full Text] [Related]
29. Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome.
Rodriguez-Viciana P; Tetsu O; Tidyman WE; Estep AL; Conger BA; Cruz MS; McCormick F; Rauen KA
Science; 2006 Mar; 311(5765):1287-90. PubMed ID: 16439621
[TBL] [Abstract][Full Text] [Related]
30. Adult mice expressing a Braf Q241R mutation on an ICR/CD-1 background exhibit a cardio-facio-cutaneous syndrome phenotype.
Moriya M; Inoue S; Miyagawa-Tomita S; Nakashima Y; Oba D; Niihori T; Hashi M; Ohnishi H; Kure S; Matsubara Y; Aoki Y
Hum Mol Genet; 2015 Dec; 24(25):7349-60. PubMed ID: 26472072
[TBL] [Abstract][Full Text] [Related]
31. Two novel germline KRAS mutations: expanding the molecular and clinical phenotype.
Stark Z; Gillessen-Kaesbach G; Ryan MM; Cirstea IC; Gremer L; Ahmadian MR; Savarirayan R; Zenker M
Clin Genet; 2012 Jun; 81(6):590-4. PubMed ID: 21797849
[TBL] [Abstract][Full Text] [Related]
32. Are cardio-facio-cutaneous syndrome and Noonan syndrome distinct? A case of CFC offspring of a mother with Noonan syndrome.
Leichtman LG
Clin Dysmorphol; 1996 Jan; 5(1):61-4. PubMed ID: 8867661
[TBL] [Abstract][Full Text] [Related]
33. Distal phalangeal creases--a distinctive dysmorphic feature in disorders of the RAS signalling pathway?
Ørstavik KH; Tangeraas T; Molven A; Prescott TE
Eur J Med Genet; 2007; 50(2):155-8. PubMed ID: 17324647
[TBL] [Abstract][Full Text] [Related]
34. LYMPHODYSPLASIA AND KRAS MUTATION: A CASE REPORT AND LITERATURE REVIEW.
Morcaldi G; Bellini T; Rossi C; Maghnie M; Boccardo F; Bonioli E; Bellini C
Lymphology; 2015 Sep; 48(3):121-7. PubMed ID: 26939159
[TBL] [Abstract][Full Text] [Related]
35. Absence of PTPN11 mutations in 28 cases of cardiofaciocutaneous (CFC) syndrome.
Ion A; Tartaglia M; Song X; Kalidas K; van der Burgt I; Shaw AC; Ming JE; Zampino G; Zackai EH; Dean JC; Somer M; Parenti G; Crosby AH; Patton MA; Gelb BD; Jeffery S
Hum Genet; 2002 Oct; 111(4-5):421-7. PubMed ID: 12384786
[TBL] [Abstract][Full Text] [Related]
36. No reason yet to change diagnostic criteria for Noonan, Costello and cardio-facio-cutaneous syndromes.
Neri G; Allanson J; Kavamura MI
J Med Genet; 2008 Dec; 45(12):832. PubMed ID: 19047498
[No Abstract] [Full Text] [Related]
37. Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: implications for therapeutic options.
Senawong T; Phuchareon J; Ohara O; McCormick F; Rauen KA; Tetsu O
Hum Mol Genet; 2008 Feb; 17(3):419-30. PubMed ID: 17981815
[TBL] [Abstract][Full Text] [Related]
38. New BRAF knockin mice provide a pathogenetic mechanism of developmental defects and a therapeutic approach in cardio-facio-cutaneous syndrome.
Inoue S; Moriya M; Watanabe Y; Miyagawa-Tomita S; Niihori T; Oba D; Ono M; Kure S; Ogura T; Matsubara Y; Aoki Y
Hum Mol Genet; 2014 Dec; 23(24):6553-66. PubMed ID: 25035421
[TBL] [Abstract][Full Text] [Related]
39. Prenatal findings in cardio-facio-cutaneous syndrome.
Templin L; Baumann C; Busa T; Heckenroth H; Pouvreau N; Toutain A; Cave H; Verloes A; Sigaudy S; Philip N
Am J Med Genet A; 2016 Feb; 170A(2):441-445. PubMed ID: 26494162
[TBL] [Abstract][Full Text] [Related]
40. Craniofacial and dental development in cardio-facio-cutaneous syndrome: the importance of Ras signaling homeostasis.
Goodwin AF; Oberoi S; Landan M; Charles C; Groth J; Martinez A; Fairley C; Weiss LA; Tidyman WE; Klein OD; Rauen KA
Clin Genet; 2013 Jun; 83(6):539-44. PubMed ID: 22946697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
